Sign in
MTRYW Stock Price, Chart, Stats & News
Monterey Bio Acquisition Corporation
Save
Monterey Bio Acquisition Corporation (MTRYW) does not currently pay a dividend.
48.30M
Market cap
–
Current P/E
–
Forward P/E
MTRYW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -10.01% |
ROA | -5.95% |
ROE | -1.86% |
D/E | – |
Interest coverage ratio | – |
MTRYW valuation
P/E | – |
P/S | – |
P/B | 1.62x |
P/CF | -31.90x |
P/FCF | -48.11x |
P/OCF | -31.90x |
PEG | -0.25x |
EV multiple | -23.76x |
About
Monterey Bio Acquisition Corporation's primary objective is to finalize a business combination with one or more entities, employing strategies such as a merger, capital stock exchange, asset acquisition, stock purchase, or corporate reorganization. Its acquisition efforts are strategically directed towards the biotechnology sector. The company was established in 2020 and is headquartered in New York, New York.
Similar securities
Based on sector and market capitalization
Report issue